19-6709693-C-T

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000064.4(C3):​c.1836G>A​(p.Thr612=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.145 in 1,612,072 control chromosomes in the GnomAD database, including 19,538 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1934 hom., cov: 28)
Exomes 𝑓: 0.14 ( 17604 hom. )

Consequence

C3
NM_000064.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -1.27
Variant links:
Genes affected
C3 (HGNC:1318): (complement C3) Complement component C3 plays a central role in the activation of complement system. Its activation is required for both classical and alternative complement activation pathways. The encoded preproprotein is proteolytically processed to generate alpha and beta subunits that form the mature protein, which is then further processed to generate numerous peptide products. The C3a peptide, also known as the C3a anaphylatoxin, modulates inflammation and possesses antimicrobial activity. Mutations in this gene are associated with atypical hemolytic uremic syndrome and age-related macular degeneration in human patients. [provided by RefSeq, Nov 2015]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.67).
BP6
Variant 19-6709693-C-T is Benign according to our data. Variant chr19-6709693-C-T is described in ClinVar as [Benign]. Clinvar id is 330317.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.27 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.42 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
C3NM_000064.4 linkuse as main transcriptc.1836G>A p.Thr612= synonymous_variant 14/41 ENST00000245907.11 NP_000055.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
C3ENST00000245907.11 linkuse as main transcriptc.1836G>A p.Thr612= synonymous_variant 14/411 NM_000064.4 ENSP00000245907 P1

Frequencies

GnomAD3 genomes
AF:
0.147
AC:
22262
AN:
151292
Hom.:
1932
Cov.:
28
show subpopulations
Gnomad AFR
AF:
0.120
Gnomad AMI
AF:
0.191
Gnomad AMR
AF:
0.126
Gnomad ASJ
AF:
0.194
Gnomad EAS
AF:
0.435
Gnomad SAS
AF:
0.260
Gnomad FIN
AF:
0.192
Gnomad MID
AF:
0.117
Gnomad NFE
AF:
0.129
Gnomad OTH
AF:
0.132
GnomAD3 exomes
AF:
0.172
AC:
43146
AN:
251408
Hom.:
4638
AF XY:
0.175
AC XY:
23748
AN XY:
135898
show subpopulations
Gnomad AFR exome
AF:
0.118
Gnomad AMR exome
AF:
0.115
Gnomad ASJ exome
AF:
0.196
Gnomad EAS exome
AF:
0.432
Gnomad SAS exome
AF:
0.232
Gnomad FIN exome
AF:
0.193
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.166
GnomAD4 exome
AF:
0.145
AC:
211286
AN:
1460662
Hom.:
17604
Cov.:
40
AF XY:
0.147
AC XY:
107013
AN XY:
726650
show subpopulations
Gnomad4 AFR exome
AF:
0.122
Gnomad4 AMR exome
AF:
0.114
Gnomad4 ASJ exome
AF:
0.200
Gnomad4 EAS exome
AF:
0.417
Gnomad4 SAS exome
AF:
0.225
Gnomad4 FIN exome
AF:
0.197
Gnomad4 NFE exome
AF:
0.126
Gnomad4 OTH exome
AF:
0.158
GnomAD4 genome
AF:
0.147
AC:
22278
AN:
151410
Hom.:
1934
Cov.:
28
AF XY:
0.153
AC XY:
11333
AN XY:
73902
show subpopulations
Gnomad4 AFR
AF:
0.121
Gnomad4 AMR
AF:
0.125
Gnomad4 ASJ
AF:
0.194
Gnomad4 EAS
AF:
0.435
Gnomad4 SAS
AF:
0.260
Gnomad4 FIN
AF:
0.192
Gnomad4 NFE
AF:
0.129
Gnomad4 OTH
AF:
0.129
Alfa
AF:
0.135
Hom.:
2218
Bravo
AF:
0.140
Asia WGS
AF:
0.303
AC:
1051
AN:
3478
EpiCase
AF:
0.128
EpiControl
AF:
0.125

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Benign, criteria provided, single submitterclinical testingGeneDxAug 02, 2018- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Age related macular degeneration 9 Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Complement component 3 deficiency Benign:2
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Atypical hemolytic-uremic syndrome with C3 anomaly Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.67
CADD
Benign
3.4
DANN
Benign
0.74

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs2230205; hg19: chr19-6709704; COSMIC: COSV55575514; COSMIC: COSV55575514; API